Publications by authors named "Sebastian Garzon"

Claim this Profile
I
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial.
María-Victoria Mateos, Bruno Paiva, M Teresa Cedena, Noemí Puig, Ana Maria Sureda-Balari

Lancet Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Survival in Patients with Multiple Myeloma over Two Decades: A Real-World Experience from a Medium-Level Hospital.
Esther Ortega-Vida, Abel Rosado-Rodriguez, Rocio Fe, Victoria Verdugo, Rocio Gavira

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WALIS dashboard: An online tool to explore a global paleo sea-level database.
Sebastián Garzón, Alessio Rovere

Open Res Eur· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study.
Enrique M Ocio, Carmen Montes-Gaisán, Gabriela Bustamante, Sebastián Garzón, Esther González

Clin Lymphoma Myeloma Leuk· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study.
Enrique M Ocio, Carmen Montes-Gaisán, Gabriela Bustamante, Sebastián Garzón, Esther González

Clin Lymphoma Myeloma Leuk· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma.
María José Cejalvo, Gabriela Bustamante, Esther González, Judith Vázquez-Álvarez, Ricarda García

Ann Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
Noemi Puig, Miguel T Hernández, Laura Rosiñol, Esther González, Felipe de Arriba

Blood Cancer J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.
Raquel Romero-García, Laura Gómez-Jaramillo, Rosa María Mateos, Gema Jiménez-Gómez, Nuria Pedreño-Horrillo

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation.
Felipe de Arriba de la Fuente, Maria Soledad Durán, Miguel Ángel Álvarez, Isabel López Sanromán, Ana Maria Dios

Semin Hematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study.
Manuel Jurado, Claudia De La Mata, Antonio Ruiz-García, Elisa López-Fernández, Olga Espinosa

Cytotherapy· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
Reyes Arranz, Eulogio Conde, Carlos Grande, Maria Victoria Mateos, Marco Gandarillas

Eur J Haematol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic abnormalities persist for more than six years after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma.
Natalia López-Holgado, Sebastiàn Garzòn, Alejandro Martín, Lourdes Hermosín, Rosa Campos

Haematologica· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis